Health
Clinical efficacy and safety of neratinib for breast cancer | DDDT – Dove Medical Press
Clinical efficacy & safety of neratinib for the treatment of adult patients with advanced or metastatic HER2 positive breast…
Introduction
Breast cancer is the most common malignancy in women (approximately 30% of total), where it represents the first cause of cancer-related death.1
From a biological point of view, breast cancer can be classified into molecularly defined subtypes,…
Continue Reading
-
Noosa News22 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man
-
Noosa News19 hours agoADF to introduce billion-dollar drone dome over Brisbane 2032
-
Business21 hours agoInvested in IAG shares? Here are the key dates for FY26
-
General17 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine